Aktive Positionen von Reinier Beeuwkes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Braintree Laboratories, Inc.
 Braintree Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA. | Direktor/Vorstandsmitglied | 01.01.1982 | - |
| Gründer | 01.01.1982 | - | |
Ischemix, Inc.
 Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Direktor/Vorstandsmitglied | 01.01.2002 | - |
Karriereverlauf von Reinier Beeuwkes
Ehemalige bekannte Positionen von Reinier Beeuwkes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CITIUS PHARMACEUTICALS, INC. | Vorstandsvorsitzender | - | 12.09.2014 |
| Vorsitzender | - | 12.09.2014 |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 2 |
| Founder | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CITIUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Braintree Laboratories, Inc.
Braintree Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Braintree Laboratories, Inc. manufactures pharmaceutical products and drugs. Its products include SUPREP, NuLYTELY and GoLYTELY. The company was founded by Harry Keegan III and Reinier Beeuwkes in 1982 and is headquartered in Braintree, MA. | Health Technology |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Health Technology |
- Börse
- Insiders
- Reinier Beeuwkes
- Erfahrung
